Retatrutide 10mg

What is RETA GLP-3?

GLP-3 peptide is described as a synthetic, multi-site peptide analog in the “glucagon-like peptide” (GLP) family. According to supplier listings it is intended for in vitro / research use only and is positioned as a next-generation peptide for exploring metabolic, appetite, weight-regulation and receptor-agonist pathways. It is not well documented in mainstream peer-reviewed literature under the name “GLP-3,” meaning the exact biological origin, receptor specificity or sequence may vary by supplier.

Chemical Structure of RETA GLP-3

Based on one supplier listing:

• Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈

• Molecular Weight: 4845.44 g/mol

• Form: Lyophilized powder for research use only.

• Storage / Handling: Supplier notes say store dry, protected from light, moisture and at low temperature; handle with proper lab protocol.

What Are the Effects of RETA GLP-3?

While formal peer-reviewed research on “GLP-3 peptide” under that name is limited, the advertised (supplier) research applications include:

• Appetite regulation and satiety pathways: some sources suggest GLP-3 may slow gastric emptying and reduce food intake in experimental settings.

• Metabolic and endocrine studies: GLP-3 is positioned for research into obesity, body composition, insulin/glucose control and energy expenditure.

• Peptide-receptor interaction and analog development: According to one vendor, it is used in laboratory assays exploring ligand binding, receptor modulation and analog structure-activity relationships.

Important caveats:

• Because GLP-3 is not widely characterized in published clinical literature, many of the claimed effects derive from analogies to GLP-1, GIP or glucagon-based receptor agonists and from supplier marketing.

• No official therapeutic claims are supported for human use under this name.

• Use is limited to qualified laboratory settings; safety, dosing, human pharmacology are not established.